RxSight Inc. (RXST)

Business: RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

IPO Date: 30-Jul-2021

Pres, CEO & Director: Dr. Ronald M. Kurtz M.D.

CFO & Assistant Sec.: Ms. Shelley B. Thunen

Listing: NASDAQ: RXST

Country: United States

Headquarters: Aliso Viejo, CA

Website: https://www.rxsight.com

Market cap: $417.53 Mln

Revenue (TTM): $28.05 Mln

Earnings (TTM): $-59.48 Mln

Cash: $143.85 Mln

Total Debt: $44.90 Mln

Insider's Holding: 21.73%

Liquidity: Low

52 Week range: $8.80 - 19.67

Shares outstanding: 27,505,100